NCT02510274View on ClinicalTrials.gov

Single and Multiple Dosing Study in Hemodialysis Patients With Hyperphosphatemia in Japan

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 12, 2014

Primary Completion Date

November 4, 2014

Study Completion Date

November 4, 2014

Conditions
Chronic Kidney DiseaseHyperphosphatemia Undergoing Hemodialysis
Interventions
DRUG

ASP3325

oral

Trial Locations (5)

Unknown

Site: 4, Aichi

Site: 5, Aichi

Site: 1, Ibaraki

Site: 2, Ibaraki

Site: 3, Shizuoka

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT02510274 - Single and Multiple Dosing Study in Hemodialysis Patients With Hyperphosphatemia in Japan | Biotech Hunter | Biotech Hunter